| UPDATED: 11:43, Wed, Feb 3, 2021 Link copied Sign up for our columnists plus the most commented stories driving conversation SUBSCRIBE Invalid email When you subscribe we will use the information you provide to send you these newsletters. Sometimes they'll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time. European Commission President Ursula von der Leyen has reignited demands for Oxford-produced coronavirus vaccines to be diverted from the UK to member states to make up for production shortfalls. It comes after the bloc sparked fury over threats to implement checks on the Northern Ireland border to prevent vaccines produced in the EU from reaching the UK – one of the main stipulations of the Brexit deal. Brussels has questioned whether AstraZeneca had previously shipped European-made doses to fulfill Britain’s order earlier this year and is now calling for their factories in the UK to work overtime to meet the bloc’s demands – but it is not the first time the pharmaceutical company has faced the possibility of being ordered around by the EU.